Shareholders in Nordic Nanovector AS voted Friday to approve an NOK250 million (US$40.6 million) private placement and to raise the offering by a further NOK50 million, evidence that Bayer AG's recently closed $2.9 billion buyout of radiopharmaceutical developer Algeta ASA has had a positive impact on investor sentiment in Norway.